Stocx Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Krishan Varma    

Surat, India

Having hands on experience in relationship management with a demonstrated history of working with the Banks/NBFCs/Leading Brokerages house etc. Thus, having adequate knowledge of the Indian capital market where we acquire the retail/HNI clients for the MF SIPs/Lump Sum, F&O, Insurance, PMS and help them to make their future life wealthy.

Read More..
Contributor since: 2022








Comments: 0 | Likes: 1 | Current Price: ₹ 418.4

Sumitomo Chemical India Ltd

Q3FY23 Result Analysis

Performance Highlights –9MFY23

- At theindustry level, over all demand, particularly in the domestic market, was sluggish during the quarter, primarily as a result of a delay in sowing due to the extended monsoons and an increase in channel inventory as a result of as lower off take during the kharif season.The  inventory levels were also high, as the level of pest infestation was relatively low.

- Domestic volume growth during the quarter were largely benign due to the challenging environment. However, the decline in demand was partially offset by improved price realization. Sharpe decline in revenue from fungiside segment resulted into modest topline growth.

- The export growth continues to remain robust, while there are some some sing of slowdonw in Latin America due to high channel inventory. Recent capacity expansion investments should help sustain this encouraging trend. The export business has witnessed growth of 39% YoY in 9MFY23.

- 4 insecticide, 1 fungicide, 1 metal phosphide and 3 PGR products launched during 9MFY23.

- The companies efforts to enhance their porduct mix, revamp our distribution reach and scaling up our capacities positions us to deliver consistent results in the future.

- The company is steps to boost growth in both domestic and international markets. In recent years, the company had prioritized filling the gap in thier portfolio, particular for certain crops and pests. 

Q3FY23 and 9MFY23 Financial Performance

Revenue Breakup


Sumitomo's Company Overview

Manufacturing Facilities

Capex Plan

Focus on R&D

3 fully equipped, DSIR approved R&D labs located at Mumbai, Bhavnagar and Gajod capable of synthesis, technical product and formulation development

R&D Team comprises of 75+ qualified and dedicated engineers & scientists of which 10+ are PhDs with more than 15 years of Experience

25+ patents granted across various geographies; 9 applications filed.

Product Pipeline

  • Multiple products coming from initiatives
  • Global Speciality Proprietary products to be launched in India
  • New combination products/pre-mixtures currently under development for domestic and exports
  • Off-patent products under development for domestic and exports
  • Technical products approved for manufacturing and exports

R&D facilities to gain capability for creating new processes and new combinations using SCC Japan’s chemistries which would help improve  production processes and efficiency.

Full Year Financial Highlights




I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Business relationship disclosure:

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Stocx Research Club). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure:

Sources of the data - Company's Investor Presentation and Press Release. Disclosure - This is not a recommendation

Disclosure legality:

I am not a SEBI Registered individual/entity and the above research article is only for educational purpose and is never intended as trading/investment advice.


Updated : Sep, 2023

Private Equity Valuation

Private Equity Valuation

Author : Mayur Kachhawa

Updated : Sep, 2023

IPO Analysis: Yatra Online

IPO Analysis of Yatra Online

Author : Shalom Martin

Updated : Sep, 2023

Nifty EPS grew around 7% in Q1FY24 and may grow 8% i...

Subdued discretionary consumer spending amid higher cost of living, higher cost of borrowings, and lingering global macro-headwinds affecting earnings

Author : Ashish Ghosh

Updated : Sep, 2023

Nifty stumbled from a lifetime high dragged by HDFC ...

Also, the diplomatic rift with Canada, fading hopes of an early election by Dec’23, and ONOE (one nation, one election) affected the Indian market

Author : Ashish Ghosh

Updated : Sep, 2023

Strong order book position and government support sh...

Tangible net worth of Salasar Techno Engineering Limited saw an improvement to INR399.60 crore in FY23 from INR281.10 crore in FY22. Overall, gearing has improved to 0.68x in FY23 in comparison to 0.86x in FY22. It has adequate liquidity position and ...

Author : TheAsianInvestor

Updated : Apr, 2023

Dharmaj Crop Guard Limited

A Business Analysis

Author : Meghna Rathod

Updated : Feb, 2023

Sumitomo Chemical India Ltd

Q3FY23 Result Analysis

Author : Krishan Varma

Updated : Dec, 2022

How will Bharat Rasayan Limited achieve next leg of ...

Focus on high growth segments and implementing critical initiatives are expected to act as growth enablers for Bharat Rasayan Limited. Wide marketing and distribution network should help Bharat Rasayan Limited to see healthy revenue growth. Strong capi...

Author : TheAsianInvestor

Updated : Dec, 2022

Sumitomo Chemical India Limited

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing...

Author : Akshay Rajawat

Updated : Oct, 2022

Heranba Industries: Business Analysis

Heranba Industries is a fully integrated crop protection chemical manufacturer based out of Vapi, Gujrat. The company is a leading producer of pyrethroid based pesticides and is present across entire value chain of the manufacturing process.

Author : Rising Investor

Updated : Jul, 2022

Equity Research: Insecticides (India) Ltd

Insecticides (India) Ltd. (IIL) is one of India’s leading manufacturers of Agrochemicals. It provides farmers with a range of products for their crop protection requirements. It also owns the prestigious “Tractor Brand” which has gained great pop...

Author : Akshita

Updated : Jun, 2022

Equity Research Report: Sakar Healthcare

Sakar Healthcare Ltd is engaged in manufacturing of pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry powder injectables and syrups. Presently, its domestic sales accounts for 31% of revenues and ...

Author : Akshita

Updated : Jun, 2022


Newgen Software Technologies is a global software Company and is engaged in the business of software product development including designing and delivering end-to-end software solutions covering the entire spectrum of software services from workflow au...

Author : Akshita

Updated : Jun, 2022

Nifty and Bank Nifty Tumbles Due to Weak Global Cues...

Nifty and Bank Nifty tumbles due to weak global cues lead by higher inflation data, higher crude oil prices and weakening currency.

Author : Shalom Martin

Updated : Jun, 2022

Equity Research Report: Shree Renuka Sugar

Shree Renuka Sugars is a global agribusiness and bio-energy corporation. The Company is one of the largest sugar producers in the world, the leading manufacturer of sugar in India, and one of the largest sugar refineries in the world.

Author : Akshita

Updated : Jul, 2022

Equity Research : Tata Consumer Products Limited

TCPL future ambitions remain aggressive, At 17% EPS CAGR over FY22-25e, TCPL should deliver industry-leading growth within indian FMCG.

Author : Shalom Martin

Updated : Jul, 2022

Equity Research: Birlasoft Ltd

Birlasoft, a small-cap IT company, has an upside potential of 35%. The company’s repeated demonstration of ‘walking the talk’ makes us believe that it is on track to achieve its stated target of USD1bn revenue by FY25E.

Author : Shalom Martin